Government-sponsored studies바카라thrice in over 15 years바카라show just three per cent of medicines in the Indian market are of substandard quality or counterfeit. But various reports, which Outlook couldn바카라t verify, peg this figure between 25 and 40 per cent. In a 2015 report, ASSOCHAM said 25 per cent of medicines sold in India are either fake or of inferior quality, the majority counterfeiting popular over-the-counter drugs sold under generic names such as Crocin and Betadine. 바카라Any study showing a higher percentage of Indian drugs as substandard or fake serves the interest of foreign pharma companies since Indian companies have always posed them a threat,바카라 says former International Pharmaceutical Federation vice president Prafull D. Shah, who played a key role in the most recent drug sample survey in 2018. Shah says he had asked ASSOCHAM for the data based on which it arrived at the 25 per cent figure, but 바카라they never provided it바카라.